ENFUSION INC - CLASS A (ENFN)

US2928121043 - Common Stock

9.415  -0.01 (-0.05%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ENFUSION INC - CLASS A

NYSE:ENFN (4/26/2024, 9:52:19 AM)

9.415

-0.01 (-0.05%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorInformation Technology
GICS IndustrySoftware
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap1.21B
Shares
PE67.25
Fwd PE42.2
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ENFN Daily chart

Company Profile

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois and currently employs 1,006 full-time employees. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real-time. Its solution comprises systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, and drives insights into and control over the business activities of the investment manager and investment operations. Its solutions end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS is able to construct and re-balance investment portfolios, this system generates a real-time investment book of record. Intertwined with its PMS, the OEMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.

Company Info

ENFUSION INC - CLASS A

125 South Clark Street, Suite 750

Chicago ILLINOIS

P: 13122539800

Employees: 1006

Website: https://enfusion.com/

ENFN News

News Imagea day ago - Market News VideoNotable Two Hundred Day Moving Average Cross - ENFN
News Image8 days ago - Enfusion, Inc.Enfusion Announces Date of First Quarter 2024 Results
News Image14 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are...

News Image22 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN). Such investors are...

News Image22 days ago - InvestorPlaceThe 3 Most Undervalued Under-$10 Stocks to Buy in April 2024

Equities have only become more expensive, but investors should still lookout for the most undervalued under-$10 stocks to buy in April.

News Image22 days ago - BusinessInsiderThe 3 Most Undervalued Under-$10 Stocks to Buy in April 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Discovering and allocating to undervalued stocks is a key element of ...

ENFN Twits

Here you can normally see the latest stock twits on ENFN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example